Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.
about
Medical management and strategies to prevent coronary artery disease in patients with type 2 diabetes mellitus.Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus.Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.Is gliclazide a sulfonylurea with difference? A review in 2016.In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.
P2860
Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of second-generation su ...... s after myocardial infarction.
@en
Effect of second-generation su ...... s after myocardial infarction.
@nl
type
label
Effect of second-generation su ...... s after myocardial infarction.
@en
Effect of second-generation su ...... s after myocardial infarction.
@nl
prefLabel
Effect of second-generation su ...... s after myocardial infarction.
@en
Effect of second-generation su ...... s after myocardial infarction.
@nl
P2093
P2860
P356
P1476
Effect of second-generation su ...... s after myocardial infarction.
@en
P2093
Adelaide M Arruda-Olson
Adrian Vella
Cynthia L Leibson
Jill M Killian
Richard K Patch
Robert L Frye
Susan A Weston
Véronique L Roger
P2860
P356
10.4065/84.1.28
P407
P577
2009-01-01T00:00:00Z